Memorial Sloan-Kettering Cancer Center | United States
Author Profile
Summary
Dr. Nora Katabi is a board-certified anatomic and clinical pathologist with extensive expertise in head and neck pathology, particularly salivary gland neoplasms. She currently serves as a Tenured Member and Attending Pathologist in the Department of Pathology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. With over two decades of academic and clinical experience, Dr. Katabi has established herself as a thought leader in oncologic surgical pathology. She actively contributes to international pathology committees and serves in editorial roles for leading scientific journals. Her career reflects a strong integration of clinical practice, translational research, education, and institutional leadership, advancing precision diagnostics in head and neck cancer.
Education
Dr. Katabi earned her M.D. from Damascus University School of Medicine, Syria, in 1997. She completed multiple externships in internal medicine, cardiovascular medicine, cytogenetics, and ambulatory cardiology at institutions including Brigham and Women’s Hospital (Harvard Medical School) and Wayne State University. She completed her residency in Anatomic and Clinical Pathology and served as Chief Resident at Baylor University Medical Center in Dallas. She then completed a fellowship in Oncologic Surgical Pathology at MSKCC, further solidifying her expertise in cancer pathology.
Professional Experience
Dr. Katabi began her tenure at MSKCC in 2006 as an Instructor and Chief Fellow, progressing to Assistant, Associate, and now Tenured Member of the pathology faculty. Clinically, she has advanced from Assistant to Attending Pathologist, specializing in surgical pathology of the head and neck. From 2017 to 2023, she served as Associate Program Director for the Oncologic Surgical Pathology Fellowship, overseeing fellow education, selection, and evaluation. She is a dedicated educator, delivering didactic lectures and participating in clinical training. Her involvement in the Fellowship Committee and numerous national and international presentations further demonstrates her leadership and academic engagement.
Research Interests
Dr. Katabi’s research focuses on histopathologic and molecular characterization of salivary gland tumors, particularly in identifying genetic alterations, molecular markers, and prognostic features. She has led multiple funded studies as Principal Investigator, including work on NR4A3 abnormalities in acinic cell carcinoma and PRKD gene alterations in polymorphous adenocarcinomas. Her additional research in squamous cell carcinoma of the head and neck contributes to improved tumor classification, grading, and clinical management. Dr. Katabi’s work supports a translational approach, bridging laboratory research with patient care to enhance diagnostic precision.
Publications
Nodal Metastasis in Low Grade Salivary Gland Carcinoma: A Retrospective Analysis of Incidence, Histologic Spectrum and Outcome
Comprehensive Clinicopathologic, Morphologic, and Molecular Evaluation and Outcomes in Polymorphous Adenocarcinoma Tumors With Applicability of a 2‑Tiered Grading System
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression
-
Author(s): Chun‑Hao Chen, Boris Reva, Nora Katabi, Avishai Wizel, Hongbo Xu, Alan L. Ho, Luc G. T. Morris, Richard L. Bakst, Anuraag S. Parikh, Yotam Drier, Sylvie Deborde, Richard J. Wong
-
Journal: Journal of Experimental Medicine